Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Two new tests for chlamydia get quick results without culture

Two new tests for chlamydia get quick results without culture Two simple new tests to detect Chlamydia trachomatis are springing onto the market virtually at once. They promise an end to an era when most physicians ignored the preponderant venereal disease-causing organism in the United States because there was no practical way to detect it. The microorganism survives only inside living cells, and the culture techniques for keeping it alive are technically demanding. One new test uses a special solution to break down cell walls of epithelial cells and employs antibodies that detect chlamydia group antigens on the surface of the exposed organisms or the extracellular elementary bodies—dead or alive— with techniques now routine in research laboratories. This enzyme-linked immunoassay, the first test to emerge, was devised by Abbott Laboratories, North Chicago, Ill, and is in limited distribution. Close on its heels is a competing method—just approved for marketing by the Food and Drug Administration—that detects the organism with a http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Two new tests for chlamydia get quick results without culture

Wingerson, Lois
JAMA , Volume 250 (17) – Nov 4, 1983
Download PDF
3 pages

Loading next page...
 
/lp/american-medical-association/two-new-tests-for-chlamydia-get-quick-results-without-culture-pKvYbpvbDy

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1983 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1983.03340170005002
Publisher site
See Article on Publisher Site

Abstract

Two simple new tests to detect Chlamydia trachomatis are springing onto the market virtually at once. They promise an end to an era when most physicians ignored the preponderant venereal disease-causing organism in the United States because there was no practical way to detect it. The microorganism survives only inside living cells, and the culture techniques for keeping it alive are technically demanding. One new test uses a special solution to break down cell walls of epithelial cells and employs antibodies that detect chlamydia group antigens on the surface of the exposed organisms or the extracellular elementary bodies—dead or alive— with techniques now routine in research laboratories. This enzyme-linked immunoassay, the first test to emerge, was devised by Abbott Laboratories, North Chicago, Ill, and is in limited distribution. Close on its heels is a competing method—just approved for marketing by the Food and Drug Administration—that detects the organism with a

Journal

JAMA – American Medical Association

Published: Nov 4, 1983

There are no references for this article.